Viewing Study NCT02133157


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-04-04 @ 10:09 PM
Study NCT ID: NCT02133157
Status: COMPLETED
Last Update Posted: 2020-07-08
First Post: 2014-03-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors
Sponsor: Hutchison Medipharma Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module